Bee Vectoring Technologies International Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Bee Vectoring Technologies International Inc. (CSE: BEE, OTCQB: BEVVF) develops and commercializes natural precision agriculture systems that utilize commercially reared bees to deliver biological pest and disease management solutions to crops. The company offers its proprietary Hive & Bees inoculum dispenser system; Vectorpak, a removable tray containing Vectorite, a patented powder formulation of natural materials; active biological ingredients including BVT-CR7, an organic strain of the endophytic fungus Clonostachys rosea; and pollen distribution systems that enable targeted application of organic compounds to inhibit crop diseases such as those affecting strawberries, sunflowers, apples, tomatoes, canola, blueberries, soybeans, cranberries, and other flowering crops and ornamentals. These solutions replace chemical pesticides through bee vectoring technology, enhancing crop yield, quality, and shelf life while promoting soil health and reducing environmental impact; the company targets growers in the global agriculture sector with operations focused on North America and expanding internationally. Founded in 2012 and headquartered in Mississauga, Ontario, Canada, Bee Vectoring Technologies holds patented and patent-pending technologies across multiple jurisdictions, with EPA registration for its vectoring delivery system since 2019. Recent developments include regulatory approval from Mexico's COFEPRIS in August 2024 for Vectorite with CR-7, enabling commercial entry into Mexico's agricultural market; strategic partnerships announced in July 2024 with agribusinesses in four North Africa and Middle East countries for commercialization; an R&D agreement in June 2024 with Syensqo to develop CR-7 as a soybean seed treatment; debt settlements closed in July 2024 to strengthen financial position; and the resignation of CFO Kyle Appleby in September 2024.
Bee Vectoring Technologies Announces Partnership Strategy Update
Bee Vectoring Technologies Announces Trials in Spain with Agrobio SL and Funded by Major EU Initiative
Bee Vectoring Technologies Announces Paid Demonstration Trials in Mexico with Major Multi-National Grower
Bee Vectoring Technologies Announces South African Trials with Major Multi-National Agribusiness
Bee Vectoring Technologies Announces Debt Settlement
Bee Vectoring Technologies Secures Up to $1 Million Loan Financing
Bee Vectoring Technologies Closes Debt Settlement
Bee Vectoring Technologies Announces Debt Settlement
Bee Vectoring Technologies to Explore Partnership Opportunities at ABIM 2023, the Top Conference for the Ag Biologicals Industry
Bee Vectoring Technologies Announces First Sale of CR-7 to BioSafe for Foliar Application
Bee Vectoring Technologies Achieves 196% Sales Growth in Pacific Northwest
Bee Vectoring Technologies Has Multiple Revenue Streams
Bee Vectoring Technologies to Present at the SNN Network Canada Virtual Event on Thursday, December 9, 2021
Bee Vectoring Technologies Signs First Commercial Industry Partnership
Bee Vectoring Technologies Announces Mutual Termination of Equity Financing Agreement with Alumina Partners Ltd.
RETRANSMISSION: Bee Vectoring Technologies Announces First-Time Revenues and Accelerated Momentum in US Sunflower Market
Bee Vectoring Technologies Announces First-Time Revenues and Accelerated Momentum in US Sunflower Market
Bee Vectoring Technologies Appoints Mark W. Kohler to Board of Directors
Bee Vectoring Technologies Adds New Territory Manager to Fast-Track Expansion in California
RETRANSMISSION: Bee Vectoring Technologies Announces First-Time Revenues in US Pacific Northwest